Mount Sinai Health System, Inc.'s Form 4 filing
GeneDx Holdings Corp. (WGS) · filed May 5, 2022
- Accession no.
- 0001209191-22-027435
- Filed
- May 5, 2022, 7:27 PM ET
- Trade date
- Apr 29, 2022
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $25.0M. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mount Sinai Health System, Inc.CIK 0001883135 | 10% Owner |
| Icahn School Of Medicine At Mount SinaiCIK 0001883139 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2022 | Class A Common Stock | PPurchaseAcquired | +6,250,000 | $4.00 | +$25,000,000 | 94,605,473 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.